Internal Medicine, Rheumatology · San Juan, PR
NPI
1962615203
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1485 Ashford Avenue, Apt. 5c#1
San Juan, PR, 00907
Phone (508) 397-0356
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,570
98 services
Medicare patients, 2024
36
Average age 73
Drug cost, 2024
$9.8M
6,909 prescriptions
Company payments, 2025
$66.59
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roxabella Torres was code 99214 (office e&m - established), 73 times for 34 patients. In total Roxabella Torres billed 98 services in 7 codes, and Medicare paid $7,570.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 73 | 34 | $87.73 | $6,405 |
By year: 2022 $5,648 for 79 services; 2023 $6,962 for 105 services; 2024 $7,570 for 98 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roxabella Torres prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,095 prescriptions and refills. In total Roxabella Torres wrote 6,909 Medicare prescriptions that cost $9.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,095 | 1,164 | 177 | $20K |
| Leflunomide Generic | 814 | 971 | 156 | $49K |
| Sulfasalazine Generic | 573 | 614 | 105 | $6,984 |
| Hydroxychloroquine Sulfate Generic | 556 | 667 | 110 | $22K |
| Alendronate Sodium Generic | 420 | 515 | 86 | $3,205 |
| Leucovorin Calcium Generic | 357 | 388 | 50 | $9,015 |
| Orencia Clickject Abatacept | 327 | 327 | 40 | $1.9M |
| Humira(Cf) Pen Adalimumab | 306 | 306 | 36 | $2.1M |
| Enbrel Sureclick Etanercept | 291 | 291 | 33 | $2.2M |
| Sulfasalazine Dr Sulfasalazine | 234 | 262 | 63 | $3,865 |
| Duloxetine Hcl Generic | 210 | 233 | 48 | $2,596 |
| Prolia Denosumab | 165 | 987 | 109 | $291K |
| Gabapentin Generic | 165 | 197 | 36 | $2,538 |
| Folic Acid Generic | 110 | 118 | 24 | $461 |
| Xeljanz Xr Tofacitinib Citrate | 90 | 90 | 13 | $524K |
Brand drugs: - claims; generic drugs: 4,218 claims; opioid claims: 73.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roxabella Torres $66.59 ($66.59 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $41.59.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.